Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
1,714
NCT02808884
Cancer DNA Screening Pilot Study (CANDACE)
Phase: N/A
Role: Collaborator
Start: Sep 19, 2016
Completion: Jun 10, 2019
NCT04995783
Predicting Medication Response for Autoimmune Disease
Role: Lead Sponsor
Start: Sep 1, 2020
Completion: Aug 1, 2022